ARK Innovation ETF (ARKK) Daily Position Changes Report
Date: April 27, 2026
Overview
On April 27, 2026, the ARK Innovation ETF (ARKK) made several significant adjustments to its holdings, primarily focusing on increasing its positions in key technology and healthcare companies. The most notable trades included substantial buys in Advanced Micro Devices (AMD) and Tesla (TSLA), indicating a bullish outlook on these sectors.
Detailed Summary
The analysis of the daily position changes reveals that ARKK increased its stake in several leading companies. Notably, AMD saw the largest increase in estimated trade value, amounting to approximately $110.09 million, reflecting a weight change of about 0.94%. Tesla also received a considerable boost with an estimated trade value of $72.10 million and a weight increase of 0.08%. Other notable increases were observed in Coinbase and Roku, both of which experienced upward adjustments in their portfolio weights.
Conversely, CRISPR Therapeutics (CRSP) and Beam Therapeutics (BEAM) were the only two holdings that saw a decrease in their portfolio weights, with CRSP experiencing a sell-off valued at approximately $7.99 million.
The overall trend suggests a strategic repositioning towards growth sectors, particularly in technology and biotech, aligning with ARK Invest's investment philosophy focused on disruptive innovation.
Position Changes Table
| Ticker | Company Name | Direction | Shares Traded | Estimated Trade Value ($) | % of Portfolio Change |
|---|---|---|---|---|---|
| AMD | Advanced Micro Devices Inc | Buy | N/A | 110,088,931.71 | 0.9363% |
| TSLA | Tesla Inc | Buy | N/A | 72,096,430.67 | 0.0769% |
| COIN | Coinbase Global Inc-A | Buy | N/A | 33,013,241.40 | 0.0251% |
| ROKU | Roku Inc-A | Buy | N/A | 32,985,654.56 | 0.0456% |
| SHOP | Shopify Inc-A | Buy | N/A | 28,099,944.51 | -0.0454% |
| CRCL | Unknown | Buy | N/A | 26,507,099.30 | -0.0359% |
| TEM | Tempus AI Inc-A | Buy | N/A | 25,339,783.64 | -0.1284% |
| HOOD | Robinhood Markets Inc-A | Buy | N/A | 17,023,043.51 | -0.1811% |
| CRSP | CRISPR Therapeutics AG | Sell | N/A | 7,991,907.76 | -0.6414% |
| BEAM | Beam Therapeutics Inc | Sell | N/A | 7,777,829.36 | -0.4249% |
Analysis and Interpretation
The recent trading activity reflects ARK Invest's ongoing commitment to capitalize on growth opportunities within the technology sector, particularly in companies poised for innovation and market disruption. The increase in holdings for AMD and Tesla aligns with the broader market trends favoring electric vehicles and semiconductor advancements.
The selling of CRISPR and Beam could indicate a tactical shift away from certain biotech positions, possibly in response to market conditions or performance metrics that no longer align with ARK's investment criteria. Overall, the adjustments made on April 27 suggest a proactive management approach aimed at optimizing the portfolio for future growth.
This concludes the daily position changes report for ARK Innovation ETF (ARKK) on April 27, 2026. Please let me know if you need further analysis or additional information!
Explore more exclusive insights at nextfin.ai.
